Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GDF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KCNE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00703 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EVC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC102B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNH7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CARD8-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC6A17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OSMR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR5B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPSB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CFLAR-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CD47 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTTG1IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KDM7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on